An Intraocular Pressure Predictive of High-risk Histopathologic Features in Group E Retinoblastoma Eyes

Overview

Journal Int Ophthalmol Clin

Specialty Ophthalmology

Date 2019 Mar 26

PMID 30908281

Citations 3

Authors

Mary E Kim

Sona Shah

Emily Zolfaghari

Rima Jubran

Mark W Reid

Jonathan W Kim

Jesse L Berry

Affiliations

Soon will be listed here.

Citing Articles

Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.

Tomar A, Finger P, Gallie B, Kivela T, Mallipatna A, Zhang C Ophthalmology. 2022; 129(8):933-945.

PMID: 35500608 PMC: 9329221. DOI: 10.1016/j.ophtha.2022.04.022.

A Proposal for Future Modifications on Clinical TNM Staging System of Retinoblastoma Based on the American Joint Committee on Cancer Staging Manual, 7 and 8 Editions.

Yousef Y, Qaddoumi I, Al-Nawaiseh I, Mohammad M, AlRimawi D, Toro M J Cancer. 2022; 13(4):1336-1345.

PMID: 35281869 PMC: 8899378. DOI: 10.7150/jca.61005.

Retinoblastoma: Etiology, Modeling, and Treatment.

Kaewkhaw R, Rojanaporn D Cancers (Basel). 2020; 12(8).

PMID: 32824373 PMC: 7465685. DOI: 10.3390/cancers12082304.

References

Singh A, Shields C, Shields J . Prognostic factors in retinoblastoma. J Pediatr Ophthalmol Strabismus. 2000; 37(3):134-41; quiz 168-9. DOI: 10.3928/0191-3913-20000501-04. View

Honavar S, Singh A, Shields C, Meadows A, Demirci H, Cater J . Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol. 2002; 120(7):923-31. DOI: 10.1001/archopht.120.7.923. View

Bellaton E, Bertozzi A, Behar C, Chastagner P, Brisse H, Sainte-Rose C . Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol. 2003; 87(3):327-9. PMC: 1771557. DOI: 10.1136/bjo.87.3.327. View

Chantada G, Dunkel I, de Davila M, Abramson D . Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?. Br J Ophthalmol. 2004; 88(8):1069-73. PMC: 1772257. DOI: 10.1136/bjo.2003.037044. View

Murphree A . Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am. 2005; 18(1):41-53, viii. DOI: 10.1016/j.ohc.2004.11.003. View

Armenian S, Panigrahy A, Murphree A, Jubran R . Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis. Pediatr Blood Cancer. 2008; 51(4):479-84. DOI: 10.1002/pbc.21604. View

Atchaneeyasakul L, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A . Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol. 2009; 53(1):35-39. DOI: 10.1007/s10384-008-0614-y. View

Chantada G, Gonzalez A, Fandino A, de Davila M, Demirdjian G, Scopinaro M . Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma. J Pediatr Hematol Oncol. 2009; 31(5):325-9. DOI: 10.1097/MPH.0b013e3181923cc5. View

Eagle Jr R . High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med. 2009; 133(8):1203-9. DOI: 10.5858/133.8.1203. View

10.

Gupta R, Vemuganti G, Reddy V, Honavar S . Histopathologic risk factors in retinoblastoma in India. Arch Pathol Lab Med. 2009; 133(8):1210-4. DOI: 10.5858/133.8.1210. View

11.

Mallipatna A, Sutherland J, Gallie B, Chan H, Heon E . Management and outcome of unilateral retinoblastoma. J AAPOS. 2009; 13(6):546-50. DOI: 10.1016/j.jaapos.2009.09.004. View

12.

Wilson M, Qaddoumi I, Billups C, Haik B, Rodriguez-Galindo C . A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma. Br J Ophthalmol. 2010; 95(4):553-8. DOI: 10.1136/bjo.2009.177444. View

13.

Chawla B, Sharma S, Sen S, Azad R, Bajaj M, Kashyap S . Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study. Ophthalmology. 2012; 119(4):850-6. DOI: 10.1016/j.ophtha.2011.09.037. View

14.

Kaliki S, Shields C, Rojanaporn D, Al-Dahmash S, McLaughlin J, Shields J . High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. Ophthalmology. 2013; 120(5):997-1003. DOI: 10.1016/j.ophtha.2012.10.044. View

15.

Kaliki S, Srinivasan V, Gupta A, Mishra D, Naik M . Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology. 2015; 122(6):1165-72. DOI: 10.1016/j.ophtha.2015.01.018. View

16.

Abramson D, Fabius A, Francis J, Marr B, Dunkel I, Brodie S . Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Ophthalmic Genet. 2017; 38(1):16-21. PMC: 5475401. DOI: 10.1080/13816810.2016.1244695. View

17.

Berry J, Kogachi K, Aziz H, McGovern K, Zolfaghari E, Murphree A . Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation. Pediatr Blood Cancer. 2017; 64(4). PMC: 7034314. DOI: 10.1002/pbc.26270. View

18.

Kim J, Madi I, Lee R, Zolfaghari E, Jubran R, Lee T . Clinical Significance of Optic Nerve Enhancement on Magnetic Resonance Imaging in Enucleated Retinoblastoma Patients. Ophthalmol Retina. 2019; 1(5):369-374. PMC: 7448757. DOI: 10.1016/j.oret.2017.03.013. View

19.

Kopelman J, McLean I, Rosenberg S . Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology. 1987; 94(4):371-7. DOI: 10.1016/s0161-6420(87)33436-0. View

20.

Shields C, Shields J, Shields M, Augsburger J . Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology. 1987; 94(7):839-46. DOI: 10.1016/s0161-6420(87)33537-7. View